These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 18704978)
1. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. Berlin HA; Hamilton H; Hollander E Mt Sinai J Med; 2008; 75(3):174-203. PubMed ID: 18704978 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder. Kochan LD; Qureshi AI; Fallon BA Curr Psychiatry Rep; 2000 Aug; 2(4):327-34. PubMed ID: 11122977 [TBL] [Abstract][Full Text] [Related]
3. Current and potential pharmacological treatments for obsessive-compulsive disorder. Davidson J; Bjorgvinsson T Expert Opin Investig Drugs; 2003 Jun; 12(6):993-1001. PubMed ID: 12783603 [TBL] [Abstract][Full Text] [Related]
4. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation. Husted DS; Shapira NA CNS Spectr; 2004 Nov; 9(11):833-47. PubMed ID: 15520607 [TBL] [Abstract][Full Text] [Related]
6. Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings. Nakao T; Okada K; Kanba S Psychiatry Clin Neurosci; 2014 Aug; 68(8):587-605. PubMed ID: 24762196 [TBL] [Abstract][Full Text] [Related]
7. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity. Brakoulias V Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422 [TBL] [Abstract][Full Text] [Related]
8. An update on obsessive-compulsive disorder. Jenike MA Bull Menninger Clin; 2001; 65(1):4-25. PubMed ID: 11280957 [TBL] [Abstract][Full Text] [Related]
19. Neuromodulation in obsessive-compulsive disorder. Bais M; Figee M; Denys D Psychiatr Clin North Am; 2014 Sep; 37(3):393-413. PubMed ID: 25150569 [TBL] [Abstract][Full Text] [Related]
20. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. Pallanti S; Marras A; Salerno L; Makris N; Hollander E J Psychopharmacol; 2016 Jun; 30(6):568-78. PubMed ID: 26843373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]